SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-23-038741
Filing Date
2023-08-07
Accepted
2023-08-07 07:24:47
Documents
76
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 6-K nams-20230630.htm   iXBRL 6-K 100893
2 EX-99.1 nams-ex99_1.htm   iXBRL EX-99.1 1313364
3 EX-99.2 nams-ex99_2.htm EX-99.2 995178
  Complete submission text file 0000950170-23-038741.txt   8758493

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nams-20230630_cal.xml EX-101.CAL 55144
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nams-20230630_pre.xml EX-101.PRE 543865
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nams-20230630.xsd EX-101.SCH 122445
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nams-20230630_lab.xml EX-101.LAB 689169
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nams-20230630_def.xml EX-101.DEF 343195
70 EXTRACTED XBRL INSTANCE DOCUMENT nams-20230630_htm.xml XML 1339558
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41562 | Film No.: 231145584
SIC: 2834 Pharmaceutical Preparations